Truth Social post of February 6, 2026

PostStatementPublished 02/06Open the original

Summary

President Trump shares an article calling the White House's launch of TrumpRx to lower prescription drug prices the biggest thing in healthcare in decades.

By industry

Healthcare & Drug Pricing1 trading day−0.1%p15 stocks5 trading days−0.2%p15 stocks20 trading days−0.6%p15 stocks

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
26/02/05	0.0%	0.0%
26/02/06	+2.4%	+2.6%
26/02/09	+1.4%	+3.1%
26/02/10	+0.1%	+3.0%
26/02/11	+1.6%	+2.9%
26/02/12	+1.2%	+1.4%
26/02/13	+2.8%	+1.3%
26/02/17	+2.8%	+1.4%
26/02/18	+2.5%	+1.9%
26/02/19	+2.0%	+1.7%
26/02/20	+1.7%	+2.5%
26/02/23	+2.4%	+1.5%
26/02/24	+1.7%	+2.1%
26/02/25	+2.0%	+3.2%
26/02/26	+1.8%	+2.0%
26/02/27	+3.8%	+1.7%
26/03/02	+3.2%	+1.8%
26/03/03	+1.7%	+0.9%
26/03/04	+1.9%	+1.9%
26/03/05	−0.5%	+1.1%
26/03/06	−0.7%	−0.1%

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$45.2M
40,956 sh
$45.2M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$38M
34,434 sh
$38M
Filed 01/08
Traded 01/07
Steven H. CollisDirector
BuyElevance Health
Buy
Elevance Health
ELV
$869.5K
3,000 sh
$869.5K
Filed 03/06
Traded 03/05
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$26.9M
24,362 sh
$26.9M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$23.2M
21,042 sh
$23.2M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$22.8M
20,668 sh
$22.8M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$22.5M
20,447 sh
$22.5M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$18.4M
16,650 sh
$18.4M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$16.4M
14,937 sh
$16.4M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$15.2M
13,701 sh
$15.2M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$14.7M
13,247 sh
$14.7M
Filed 01/08
Traded 01/07
Joaquin DuatoCEO and Chairman
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$11.3M
51,218 sh
$11.3M
Filed 01/28
Traded 01/26
Joaquin DuatoCEO and Chairman
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$10.8M
48,782 sh
$10.8M
Filed 01/28
Traded 01/26
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$10.5M
9,573 sh
$10.5M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$10.1M
9,053 sh
$10.1M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$9.4M
8,513 sh
$9.4M
Filed 01/08
Traded 01/07
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$8.4M
7,684 sh
$8.4M
Filed 01/08
Traded 01/07
Joseph J. WolkExec VP, CFO
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$8.1M
33,386 sh
$8.1M
Filed 02/18
Traded 02/17
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$7M
6,408 sh
$7M
Filed 01/08
Traded 01/07
Joseph J. WolkExec VP, CFO
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$6.1M
24,961 sh
$6.1M
Filed 02/18
Traded 02/17